SCHEMBL13801124

SCHEMBL13801124

c1cc2cccc3c4ccc(-c5nc6sc(-c7ccc8c9cccc%10cccc(c%11cccc7c%118)c%109)nc6s5)c5cccc(c(c1)c23)c54

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
HSD17B10 Q99714 5/20 0.38
HPGD P15428 4/20 0.38
CYP1A2 P05177 3/20 0.38
THRB P10828 1/20 0.38
ERBB2 P04626 1/20 0.35
FYN P06241 1/20 0.35
MAOA P21397 1/20 0.35
ACHE P22303 1/20 0.35
AHR P35869 1/20 0.35
ALOX15 P16050 1/20 0.33
HTR2C P28335 1/20 0.33
PPARG P37231 2/20 0.32
RXRA P19793 1/20 0.32
PPARD Q03181 1/20 0.32
PPARA Q07869 1/20 0.32
TSHR P16473 3/20 0.32
MAPK1 P28482 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25028182 0.87 ALDH1A1 (0.42) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL13945316 0.85 CYP1A2 (0.42) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL13801125 0.84 ALDH1A1 (0.45) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL13801123 0.80 CRHBP (0.46) ALDH1A1HSD17B10HPGDCYP1A2ALOX15
SCHEMBL13801112 0.77 ALOX15 (0.50) ALDH1A1HSD17B10HPGDALOX15HTR2C
SCHEMBL13801126 0.74 CYP1A2 (0.38) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL14506046 0.74 ALDH1A1 (0.37) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL12431914 0.72 ALDH1A1 (0.46) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL14506048 0.71 ALDH1A1 (0.36) ALDH1A1HSD17B10HPGDCYP1A2THRB
SCHEMBL30661082 0.71 ALDH1A1 (0.50) ALDH1A1HSD17B10HPGDCYP1A2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090156827-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT TOYO INK MFG. CO., LTD. (JP) 2009-06-18 US disclosed
US-20090156827-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT TOYO INK MFG. CO., LTD. (JP) 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156827-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT ELP1, ELAVL1, ELF3 ALDH1A1 1089/4885HSD17B10 4517/4885HPGD 4218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.